HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analogs of neurokinin A(4-10) afford protection against gastroduodenal ulcers in rats.

Abstract
We have developed a novel series of peptides, related to the NKA(4-10) sequence, in which substitution of selected amino acids determined variations in the affinity for the TK receptor subtypes. Subcutaneous pretreatment of rats with some peptides of this series reduced gastric ulcers induced by ethanol, indomethacin or acetylsalicylic acid (ASA) as well as duodenal ulcers induced by dulcerozine. In particular [Ala5]NKA(4-10) and [Ala5,beta Ala8]NKA(4-10) possess a broad spectrum of antiulcer activity which is long lasting and stronger than the precursor NKA(4-10). The observation that the prevention of ethanol-induced gastric lesions could be reversed by pretreatment with indomethacin favors the possible involvement of prostaglandins in the observed gastroprotection by TK analogs.
AuthorsS Evangelista, C A Maggi, P Rovero, R Patacchini, S Giuliani, A Giachetti
JournalPeptides (Peptides) 1990 Mar-Apr Vol. 11 Issue 2 Pg. 293-7 ISSN: 0196-9781 [Print] United States
PMID2162531 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptide Fragments
  • Receptors, Neurotransmitter
  • Receptors, Tachykinin
  • Neurokinin A
  • neurokinin A(4-10)
Topics
  • Amino Acid Sequence
  • Analysis of Variance
  • Animals
  • Female
  • Male
  • Molecular Sequence Data
  • Neurokinin A (metabolism, pharmacology)
  • Peptic Ulcer (prevention & control)
  • Peptide Fragments (metabolism, pharmacology)
  • Premedication
  • Rats
  • Rats, Inbred Strains
  • Receptors, Neurotransmitter (metabolism)
  • Receptors, Tachykinin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: